As the midterm election year gets underway, voters are already drawing clear lines between the Democratic and Republican parties on the issues. A new Fox News survey, released Thursday, finds the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company plans to use an ...

As Dhurandhar continues to tell cinegoers that Pakistan’s deep state views Hindus as pushovers, Border 2 arrives to underscore that the 1971 War stemmed from the neighbour’s belief that Indians are ...

NEW DELHI: In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its blockbuster cancer drug Venetoclax citing lack of inventive step.

Democrats are ahead of Republicans by 6 percentage points on a generic congressional ballot, according to a poll released Thursday. In the Emerson College poll, 48.1 percent of respondents backed a ...

HYDERABAD, Jan 21 (Reuters) - Indian drugmaker Dr Reddy's (REDY.NS), opens new tab, which reported a smaller-than-expected fall in quarterly profit on Wednesday, said that it has received an approval ...

The Democratic Party has a deeply motivated base and a clear advantage on the generic congressional ballot ahead of this fall’s midterms despite dismal impressions of its current leaders in Congress, ...

Indian pharmaceutical companies head into 2026 with a clearer tilt towards specialty medicines as sustained pricing pressure continues to weigh on returns from traditional generics. With export ...

Albertans may see more and less-expensive varieties of Ozempic on the market soon, after a patent on the drug expired two weeks ago. Ozempic has made headlines in recent years as a popular weight-loss ...

British Columbians could soon have access to cheaper versions of injectable diabetes and obesity drugs. Health Canada is reviewing nine submissions for generic versions of semaglutide, a prescription ...

The big medical news of 2026 is about the big blockbuster drug of 2025. Semaglutide (a.k.a. Ozempic, a.k.a. Wegovy) is now off patent in Canada. In the U.S. and the rest of the world, patent ...

Jithin (name changed) was an autorickshaw driver in Kerala, ferrying schoolchildren through the crowded lanes every morning and evening. His modest earnings barely covered food and his children’s ...